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To study the effect of small interfering RNA targeting metastasis-associated lung adenocarcinoma 
transcript1 (si-MALAT1) combining with curcumin on the invasion and migration abilities of human 
colon cancer SW480 cells, and to explore the involved molecular mechanism. The recombinant lentiviral 
vector expressing si-MALAT1 was constructed, and its titer was determined by gradient dilution 
method. The colon cancer SW480 cells with stable expression of si-MALAT1 was established, followed 
by treatment with curcumin at different concentrations. The effect of curcumin or si-MALAT1 alone 
and the combination of the two on the cell activity was detected by MTT assay. The cell invasion and 
migration abilities were detected by transwell and scratch-wound assay. The relative expression level of 
MALAT1 was detected by RT-qPCR. The protein expression was determined by Western blot analysis. 
The IC50 of curcumin alone was 77.69 µmol/L, which was 51.17 mol/L when combined with curcumin 
and random sequence. The IC50 of curcumin was 30.02 µmol/L when combined with si-MALAT1. 
The increased susceptibility multiples was 2.58. The wound healing rates were 30.9% and 67.5% after 
treatment with si-MALAT1 combined with curcumin for 24 hrs and 48 hrs, respectively. The numbers of 
invasion cells were 200±12, 162±13, 66±8, 53±4 and 16±3 after treatment with si-MALAT1 combined 
with curcumin for 48 hrs. The relative expression level of lncRNA-MALAT1 in the curcumin group was 
68%, and the relative expression level of lncRNA-MALAT1 in si-MALAT1group was 56%, and that for 
the combination treatment group was about 21%. The protein expression levels of β- catenin, c-myc and 
cyclinD1 were significantly down-regulated upon treatment with certain concentration of si-MALAT1 
alone or combined with curcumin.si-MALAT1 could significantly inhibit the invasion and migration of 
SW480 cells by enhancing the sensitivity of SW480 cells to curcumin. The mechanism involved mignt 
be related to the down-regulation of β-catenin, c-myc and cyclinD1 proteins.
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cancer. Invasion. Migration. Colonic Neoplasms/ prevention & control. Colonic Neoplasms/ drug therapy. 
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INTRODUCTION
Colon cancer is the third most common malignant 
tumor in the world, and its morbidity and mortality are 
increasing year by year. Patient received post-operation 
adjuvant chemotherapy is prone to death due to metastasis 
and recurrence (Torre et al., 2015; Burt, 2013). Therefore, 
it is urgent to clarify its pathogenesis and improve the 
therapeutic effect.
Long-chain non-coding RNA (lncRNA) is a type 
of non-coding RNAs with a length of more than 200 
nucleotides. It is involved in many physiological and 
pathological processes, and considered to be closely 
related to the occurrence and development of tumor. 
They can also play roles in both tumor suppression and 
cancer promotion. However, the study of the molecular 
mechanism of lncRNA regulation is still at a preliminary 
stage (Fatima et al., 2015). Studies have shown that the 
abnormal expression of lncRNA was associated with 
the growth and invasion of colon cancer cells (MA et 
al., 2016). Metastasis-related lung adenocarcinoma 
transcript 1 (Metastasis-associated lung adenocarcinoma 
transcript 1, MALAT1) is widely expressed in human 
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normal tissue, especially in pancreas and lung tissues 
(Zheng et al., 2014). It is also found to be highly expressed 
in colon cancer tissues. Its expression and neural 
infiltration could affect the invasion and migration of 
colon cancer cells, and therefore were considered as two 
independent risk factors for the poor prognosis of colon 
cancer patients (Ji et al., 2014).
Compared to the current conventional treatment 
strategy for cancer, traditional Chinese medicine has the 
advantages of low toxicity and being able to improve the 
patient’s immunity. It will have unparalleled advantages in 
cancer prevention, early cancer treatment, and even in the 
application of middle and late stage cancer. Curcumin, a 
diketone compound, a substance derived from the family 
Curcumin. It has been shown to have anti-inflammation, 
anti-oxidation and anti-tumor effects, as well as reducing 
blood lipids (Anand et al., 2008). Curcumin was also 
found to be able to inhibit invasion and metastasis of colon 
cancer cells, but the molecular mechanism involved is still 
not clear (Kunnumakkara, Anand, Aggarwal, 2008).
In this study, small interfering RNAs (siRNAs) 
were used to reduce the level of MALAT1 expression in 
colon cancer SW480 cells, which were further treated 
with curcumin.We aimed to determine the effect of this 
combination treatment on the viability and migration of 
colon cancer SW480 cells, and further clarify the potential 
molecular regulatory mechanism involved. It will provide 
the theoretical basis for the clinical treatment of colon 
cancer using integrated Chinese and western medicine.
MATERIAL AND METHODS
Material
Liposome LipofectamineTM2000 was purchased 
from Invitrogen Company; DMEM/F12 medium was 
purchased from Hyclone Company; RIPA cell lysate 
(Shanghai Sheneng betting Biotechnology Co., Ltd.); 
BCA protein concentration determination kit (Beijing 
Boosen Biotechnology Co., Ltd.). MTT reagent from the 
Japanese Institute of Tongren Chemistry; RNA extraction 
reagent TRIzol (Invitrogen Company; ECL kit (Biyuntian 
Biotechnology Research Institute); Polyclonal resistance 
to β -catenin c myc and c YclinD1 antibody, monoclonal 
GAPDH antibody (Cell Signaling, USA); Curcumin was 
purchased from Sigma Company of USA and dissolved 
into 10 mmol/L standby with DMSO. The recombinant 
lentivirus plasmid pLVX-shRNA2 and the packaging 
plasmid PLD2 were obtained From Shanghai Jima Co., L). 
And encapsulated plasmid PLD3 is provided by Shanghai 
Jima Co., L.
Cell culture
Colon cancer SW480 cells were purchased from 
Shanghai Cell Bank Center. The cells were cultured in 
DMEM / F12 contained 10% newborn bovine serum 
at 37℃ in the incubator containing 5% CO2. Cells was 
digested and subcultured with 0.25% trypsin every 
2-3 days. Cells with trypan blue rejection rate > 95% 
in logarithmic growth period were used for further 
experimentation.
Construction of colon cancer SW480 cells stably 
expressing siRNA-MALAT1
The sense chain of siRNA sequence of MALAT1 
was 5’-GAGGUGUAAAGGUUUAUTT-3’.  The 
an t i sense  cha in  was  5 -AUA-AAAUCCCUUU 
ACACCUCTT-3; The sense chain of random sequence was 
5’-UUCUCCGAACGUGUC ACGUTT-3’. The antisense 
chain was 5-ACGUGACACGUCGGAGAATT-3; the 
construction of siRNA-MALAT1expressing lentiviral 
vector was conducted by Shanghai Jima Limited 
Technology Co., Ltd. Recombinant lentivirus plasmids, 
packaging plasmids PLD2 and encapsulated plasmids 
PLD3 were co-transfected into 293T cells. 24 hrs after 
the transfection, 10 mL fresh complete culture medium 
(containing 1% pairs of antibodies) was replaced. The 
virus-containing supernatant was then collected after 48 
hrs, and then continuously diluted with a gradient of 10 
times on a 48-well cell culture plate. The 10 μL of the 
diluted virus-containing supernatant was then added to 
the cell culture. After 48 hours of cultivation, the collected 
supernatant was diluted. The fluorescent cells were 
counted under inverted fluorescence microscope. The 
titer of the virus was defined by transducing units (TU). 
The virus titer was calculated according to the following 
formula: (Tu / m)= (green fluorescent cell number / field 
of vision) × (visual field number / hole number) × virus 
dilution multiple / virus volume . The SW480 cells were 
then infected with packaged lentivirus. The SW480 cell 
lines expressing stably siRNA-MALAT1 were established 
according to the instructions.
MTT assay
SW480 cells in logarithmic growth phase were 
cultured in serum-free DMEM/F12 medium. The cell 
concentration was adjusted to 1 × 105 cells / mL, and 
then 100 μL per well of the cell suspension inoculated in 
a 96-well plate. The cells were divided into two groups: 
blank control group (no treatment);si-MALAT1 group 
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(treated with 10 μmol/L of si-MALAT1); si-MALAT1 
combined with curcumin group (treated with 15μmol/L 
of si-MALAT1 and curcumin); Negative control group 
(treating with 15μmol / L of random sequence) and the 
Curcumin group (treated with 5, 10,20,40 and 80 μmol/L 
of curcumin); after 48 hrs of cultivation, 20μL of MTT 
solution was added to each well. After 4 hrs, the culture 
medium was carefully discarded, and 150 μL DMSO 
was added to each well. The resultant violet crystal was 
completely dissolved by oscillating at low speed for 
10 min. The absorbance of each well was measured at the 
wavelength of 490 nm and the average value was obtained. 
Transwell assay
The Matrigel was diluted in serum-free DMEM/
F12 medium and then added into the transwell chamber.
containing 8 μm small polycarbonate filter membrane. 
5×105 of SW480 cells were diluted in 100μL serum-
free medium, and 600μL of the DMEM/F12 medium 
containing 10% serum was added in the lower chamber. 
Each group was cultured for 24 hrs in triplicate at 37℃ 
in the incubator containing 5% CO2. Cells in the culture 
chamber was then removed and fixed with methanol for 
20 mins, followed by staining with 1% crystal violet for 
20 mins. The matrix glue and the non-invasive cells at 
the bottom of the upper chamber were gently wiped off 
with wet cotton swabs, then the chamber was inverted. 
The number of cells passing through the membrane was 
counted under the 100x optical microscope.
Scratch-wound assay
5×105 of SW480 cells were added to each well of 
a 12-well plate and allowed to grow until a confluent 
monolayer was formed. Then the cell monolayer was 
scraped in a straight line to create a gap with a pipet tip. 
The cell debris was then removed by washing with 1xPBS 
for 3 times. Culture medium was then added again and 
cells were allowed to grow for 48hrs before taking the 
microscopy imagines. The distance between one side 
of scratch and the other was measured using Image J 
software.
Detection of relative expression level of MALAT1 
by RT-qPCR
M-MLV Reverse Transcriptase was used for the 
reverse transcription of mRNA to complementary DNA 
(cDNA), which was later used as the PCR template. Each 
experiment was performed in triplicate. The expression 
levels of U6 and U6 was used as an internal control for 
mRNAs. The sense chain sequence of primer. MALAT1 
was 5’-AGGCGTTGTGGTAGAGA-3’. The sequence 
of antisense chain is 5 GGATTTACCAACCACTCGC-3; 
The sense chain sequence of U6 was 5’-CTCGCTT 
CGGCAGCACA3’. The antisense sequence was 5 
AACGCTTCACGAATTTGCGT-3. Using U6 as internal 
reference, the relative expression of MALAT1 was 
calculated. 
Western blot analysis
The cell was lysed in RIPA buffer containing a 
proteinase inhibitor cocktail (Biocolor BioScience & 
Technology, Shanghai, China). After centrifugation 
at 4 °C for 15 mins, the pellets were discarded. The 
protein concentration of each group was determined 
by bicinchoninic acid (BCA) Protein Assay Kit (Bioss, 
Beijing, China). The protein was then separated on the 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) and electrotransferred to PVDF membranes. 
GAPDH was used as the internal reference. The ratios of 
β-catenin,c-myc,cyclinD and GAPDH were calculated and 
interpreted as the relative expressions of β-catenin,c-myc 
and cyclinD1 proteins. All experiments were repeated for 
three times (absolute gray value = gray value - background 
gray value).
Statistical analysis
All the results were represented the average of at 
least three independent experiments. Data were expressed 
as the mean ± SD and analyzed by one-way analysis of 
variance (ANOVA) and Student’s t test. A p<0.05 was 
considered statistically significant.
RESULTS
The lentiviral vector expressing si-MALAT1 was 
successfully constructed
The recombinant lentiviral plasmid, packaging 
plasmid PLD2 and the envelope plasmid PLD3 were 
co-transfected into 293T cells. The virus-containning 
supernatant was then collected at 72 h, which viral titer 
was 1x109 TU/mL determined using 10 times continuous 
gradient method(Figure 1A). The GFP virus expression 
was observed by fluorescence microscope (Figure 1B). 
Sequencing results of the recombinant plasmid products 
were completely compatible with the designed primer 
sequences using the Blast ratio. It suggested that the 
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lentivirus expression vector was successfully constructed 
(Figure 1C).
Curcumin combined with si-MALAT1 inhibited the 
SW480 cell viability
The IC50 of curcumin alone was 77.69 umol·L-1. 
The IC50 of curcumin combined with random sequence 
was 51.17 umol·L-1; The IC50 of curcumin combined 
with si-MALAT1 mimics was 30.02 umol·L -1. The 
results showed that curcumin combined with si-MALAT1 
could significantly inhibit the viability of SW480 cells 
(Figure 2).
Curcumin combined with si-MALAT1 inhibited the 
migration of SW480 cell
SW480 cells were treated with certain concentration 
of si-MALAT1 mimics, random sequences, curcumin 
and si-MALAT1mimics on for 24 h or 48 h. The wound 
healing rate of the curcumin group alone was 30.9% and 
67.5% after treatment for 24 h and 48 h, respectively. The 
wound healing rate of si-MALAT1 mimics combined with 
curcumin group was 15.75% and 24.8% after treatment 
for 24 h and 48 h, respectively. The si-MALAT1 analogue 
combined with curcumin group had significantly lower 
wound healing rate than those of the blank control group 
and the negative control group (P < 0.05).There was 
no significant difference between the negative control 
group and the blank control group (P > 0.05).The results 
suggested that Si-MALAT1 combined with curcumin 
could significantly inhibit the migration of SW480 cells. 
(Figures 3A and B)
Curcumin combined with si-MALAT1 inhibited the 
invasion of SW480 cell
Result from the transwell assay showed that, the 
number of invasion cells for the blank control group, 
the negative control group, the curcumin group, and the 
curcumin combined with si-MALAT1 mimics group 
were 200±12,162±13,66±8,53±4and16±3, respectively. 
The number of invasion cells in the curcumin combined 
with si-MALAT1 mimics group was significantly lower 
than those in other groups (P < 0.05). It suggested that 
si-MALAT1 combined with curcumin could inhibit the 
invasion of SW480 cells (Figure 4).
Curcumin combined with si-MALAT1 inhibited the 
expression of MALAT1
SW480 cells were treated with curcumin alone or 
combined with si-MATAT 1 at a certain concentration 
for 48 hrs, and the expression of lncRNA-MALAT1 was 
then detected by real-time quantitative PCR. The results 
showed that the relative expression levels of lncRNA-
MALAT1 were 68%, 56% and 21% in the curcumin 
group, the si-MALAT1 group, and the combination 
treatment group, respectively. The difference between 
the combination treatment group and the single treatment 
group was statistically significant (P < 0.05) (Figure 5).
Curcumin combined with si-MALAT1 down-
regulated the protein expression of c-myc, 
cyclinD1 and β-catenin
si-MALAT1 was transfected into SW480 cells for 
48 h. The results of Western blotting showed that the 
FIGURE 1 - Determination of lentivirus titer and identification 
of recombinant plasmid products by sequencing. A: The 
recombinant plasmid expressing si-MALAT1 was observed 
under fluorescence microscope (40x); B: The plasmid expressing 
empty vector was observed under fluorescence microscope; C: 
Identification of recombinant plasmid products by sequencing .
FIGURE 2 - Cell inhibition rates in the curcumin group, the 
curcumin and random sequence group, and the curcumin and 
si-MALAT1 group *P<0.05, △P> 0.05, n=3.
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protein expression levels of β-catenin, c-myc and cyclinD1 
were significantly down-regulated when treatment with 
certain concentration of si-MALAT1 mimics alone or 
combined with curcumin (Figure 6).
DISCUSSION
Colon cancer is one of the most common malignant 
tumors of digestive tract in the world, which is seriously 
threatening human life and health. The occurrence and 
development of colon cancer is a multi-step process. The 
mortality rate of colon cancer in China is as high as 60%. 
The conventional treatment for early colorectal cancer 
is surgical resection. The 5-year survival rate can reach 
90% to 95%. The metastasis and invasion of colon cancer 
are the main causes of postoperative recurrence and the 
death of patients (Wu et al., 2014). Therefore, clarifying 
the molecular mechanism involved in the invasion and 
metastasis of colon cancer cells will shed the light on the 
development of effective therapeutic treatment strategy 
for colon cancer, and hopefully lower its mortality rate.
The differential expression of lncRNA in colon 
cancer is closely related to clinical features, suggesting 
that lncRNA is involved in the invasion and metastasis 
of colon cancer (Chen et al., 2016). Some studies have 
shown that lncRNA-MALAT1 was highly expressed in 
colon cancer tissues, and high expression of lncRNA-
MALAT1 was associated with poor prognosis and lower 
chemotherapeutic tolerance (Mercer, Dinger, Mattick, 
2009). Curcumin is a type of polyphenols extracted from 
the rhizomes of turmeric and other plants. It has a wide 
range of pharmacological usage. It has been shown that 
FIGURE 3 - The migration ability of SW480 cells was detected by transwell assay. A: The cell migration distance of each group 
after treatment for 24 h or 48 h was observed under fluorescence microscope (40X); C: The quantitative analysis of of the wound 
healing rates in each group after treatment for 48hrs. Mean±SD. n= 3. * P<0.05, * * P<0.05.
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curcumin could inhibit metastasis and induce apoptosis in 
many kinds of tumors (Zhou et al., 2014).
In this study, the small interfering RNA sequence for 
MALAT1 was designed, and the recombinant lentivirus 
plasmid pLVX-shRNA2 was ligated with the encapsulated 
plasmid. The recombinant lentivirus plasmid si-MALAT1 
was constructed, and used for infecting SW480 cells to 
establish a stable cell line expressing si-MALAT1. At the 
same time, the combination of si-MALAT1 with different 
concentrations of curcumin could significantly increase 
the sensitivity of SW480 cells to curcumin after treatment 
for 48 hrs. Curcumin combined with si-MALAT1 could 
inhibit migration and invasion of SW480 cells. 
Wnt signaling pathway is not only closely related 
to embryonic development, but also contributes to human 
tumorigenesis (Heintze et al., 2017). β-catenin avoids 
FIGURE 4 - The invasion ability of SW480 cells in different groups was evaluated by scratch-wound assay. A: The invasion cells 
in each group were observed under fluorescence microscope (40X; B: The quantitative analysis of the invasion cells in each group: 
1: Control group; 2: Negative control group; 3: Curcumin group; 4: si-MALAT1 group; 5: Curcumin combined with si-MALAT1 
group. Mean±SD. n=3 . * P<0.05 vs other groups.
FIGURE 5 - The effect of curcumin on the expression of 
lncRNA-MALAT1 in the human colon cancer SW480 cells. 
Mean±SD. n=3 . * P<0.05 vs other groups.
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FIGURE 6 - The relative protein expression levels of β-catenin, 
c-myc and cyclinD1 detected by Western-blotting. A:β-catenin, 
c-myc and cyclinD1 expression in different treatment groups; 
B:.The relative protein expression levels of catenin, c-myc 
and cyclinD1 in different treatment groups, Mean±SD. n=3 .* 
P<0.05 vs other groups.
degradation through ubiquitin proteasome pathway and 
enters nucleus aggregation to activate downstream target 
genes such as c-myc. Expression of cyclin D1 and VEGF 
can promote tumor occurrence and metastasis (Bienz, 
Clevers, 2000). In this study, 48 hrs after treatment with 
curcumin and si-MALAT1, the expression of MALAT1 
in SW480 cells was down-regulated. At the same time, 
the protein expression of cyclin D1, β-catenin and c-myc 
was also decreased. The results suggested that curcumin 
combined with si-MALAT1 could inhibit the proliferation 
of SW480 cells. Migration and invasion of SW480 cells 
were achieved by down-regulating MALAT1 and down-
regulating cyclin D1.
β-catenin and c-myc in the Wnt signaling pathway 
.Curcumin could obviously suppress the growth of SW620 
in colon cancer cells in vitro and in vivo through inhibiting 
the Wnt signaling pathway by up-regulating the expression 
of NKD2 gene, and then, down regulating expression 
of CXCR4 in tumor cells, which further inhibited the 
invasion and metastasis of tumor cells (Akira et al., 2000).
CONCLUSIONS
In conclusion, this study demonstrated in vitro 
that, curcumin combined with si-MALAT1 inhibited the 
viability, migration and invasion of SW480 cells by down-
regulating the expression MALAT1. And down-regulating 
the expression of β -catenin, c-myc and cyclin D1 in Wnt 
signaling pathway. However, the in vivo effect of curcumin 
needs to be further elucidated. The present study provides 
the theoretical basis for the clinical treatment of colon 
cancer using integrated Chinese and western medicine, 
and will hopefully aid the development of new therapeutic 
treatment strategy for colon cancer in the near future.
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